OPDIVO is a prescription medicine for small cell lung cancer (SCLC) treatment.
INDICATIONS AND USAGE
OPDIVO is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of:
Melanoma, Non-Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma, Renal Cell Carcinoma (RCC)
Classical Hodgkin Lymphoma (cHL), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Squamous Cell Carcinoma (ESCC).
DOSAGE FORMS & STRENGTHS
Injection: 40 mg/4 mL, 100 mg/10 mL, and 240 mg/24 mL solution in a single-dose vial.
Manufactured By: Bristol-Myers Squibb.
Prescribing Information URL: Click Here
South Delhi Pharma can facilitate the supply of “OPDIVO (nivolumab) injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer. This includes melanoma, lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, colon cancer, and liver cancer. It is used by slow injection into a vein.[
Nivolumab was approved for medical use in the United States in 2014. It is on the World Health Organization's List of Essential Medicines. It is made using Chinese hamster ovary cells.